The FDA’s Decision to Pause J&J Could Help Defeat Covid-19

Simple item page
dc.contributor.authorMcLaren, Zoe
dc.date.accessioned2021-12-03T16:57:33Z
dc.date.available2021-12-03T16:57:33Z
dc.date.issued2021-04-16
dc.descriptionPhotographer: Michael Ciagloen_US
dc.description.urihttps://www.wired.com/story/fda-decision-pause-jandj-could-help-defeat-covid/en_US
dc.genrearticlesen_US
dc.identifierdoi:10.13016/m2rj4a-tsps
dc.identifier.citationMcLaren, Zoe; The FDA’s Decision to Pause J&J Could Help Defeat Covid-19; Ideas, 16 April, 2021; https://www.wired.com/story/fda-decision-pause-jandj-could-help-defeat-covid/en_US
dc.identifier.urihttp://hdl.handle.net/11603/23516
dc.language.isoen_USen_US
dc.publisherWireden_US
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC School of Public Policy Collection
dc.relation.ispartofUMBC Faculty Collection
dc.rightsThis item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.en_US
dc.subjectJohnson & Johnson’s Covid-19 vaccineen_US
dc.subjectvaccine hesitancyen_US
dc.subjectFood and Drug Administrationen_US
dc.titleThe FDA’s Decision to Pause J&J Could Help Defeat Covid-19en_US
dc.typeTexten_US
dcterms.creatorhttps://orcid.org/0000-0003-2515-9731en_US

Files

License bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.56 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

UMBC School of Public Policy
UMBC Faculty Collection